ATE79264T1 - Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind. - Google Patents

Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.

Info

Publication number
ATE79264T1
ATE79264T1 AT86304408T AT86304408T ATE79264T1 AT E79264 T1 ATE79264 T1 AT E79264T1 AT 86304408 T AT86304408 T AT 86304408T AT 86304408 T AT86304408 T AT 86304408T AT E79264 T1 ATE79264 T1 AT E79264T1
Authority
AT
Austria
Prior art keywords
campylobacter
bismuth
treatment
polyridis
medications
Prior art date
Application number
AT86304408T
Other languages
English (en)
Inventor
Barry James M D Marshall
Original Assignee
Barry James M D Marshall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24994180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE79264(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Barry James M D Marshall filed Critical Barry James M D Marshall
Application granted granted Critical
Publication of ATE79264T1 publication Critical patent/ATE79264T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT86304408T 1985-06-13 1986-06-10 Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind. ATE79264T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74484285A 1985-06-13 1985-06-13
EP86304408A EP0206626B2 (de) 1985-06-13 1986-06-10 Verwendung von Bismuth zur Herstellung von Medikamenten zur Behandlung von Magen-Darmstörungen, die von Campylobacter polyridis verursacht sind

Publications (1)

Publication Number Publication Date
ATE79264T1 true ATE79264T1 (de) 1992-08-15

Family

ID=24994180

Family Applications (2)

Application Number Title Priority Date Filing Date
AT86304409T ATE79261T1 (de) 1985-06-13 1986-06-10 Verfahren zur behandlung von magen-darmstoerungen.
AT86304408T ATE79264T1 (de) 1985-06-13 1986-06-10 Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT86304409T ATE79261T1 (de) 1985-06-13 1986-06-10 Verfahren zur behandlung von magen-darmstoerungen.

Country Status (8)

Country Link
US (1) US5601848A (de)
EP (2) EP0206627B1 (de)
JP (1) JPH0794391B2 (de)
AT (2) ATE79261T1 (de)
BE (1) BE904922A (de)
DE (4) DE3686361T3 (de)
IE (2) IE59584B1 (de)
PH (1) PH26891A (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
WO1989003219A1 (en) * 1987-10-12 1989-04-20 Borody Thomas J Improved method for treatment of gastrointestinal disorders
EP0348143A3 (de) * 1988-06-21 1991-03-13 MARION LABORATORIES, INC. (a Delaware corporation) Bismuth-Derivate von Saccharid-Phosphaten und Sulfaten
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
NL9220019A (nl) * 1992-04-10 1994-04-05 Vnii Med Polimerov Farmaceutische samenstelling.
US5376553A (en) * 1993-06-18 1994-12-27 University Of Florida Clinical marker and therapeutic agent in kidney stone disease and methods of use
AU7833194A (en) * 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
WO1995012579A1 (en) * 1993-11-05 1995-05-11 Otsuka Pharmaceutical Company, Limited Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US5607964A (en) * 1994-06-17 1997-03-04 University Of Florida Clinical marker and therapeutic agent in kidney stone disease and methods of use
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
BR9611913A (pt) * 1995-12-07 1999-03-02 Procter & Gamble Composições contendo bismuto para a prevenção e tratamento de distúrbios gastrintestinais
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
GB9623962D0 (en) * 1996-11-15 1997-01-08 Tillotts Pharma Ag Pharmaceutical composition
US6186958B1 (en) 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
USRE38728E1 (en) * 1997-09-11 2005-04-19 Oridion Medical, LTD Breath test analyzer
USD467348S1 (en) 2001-10-15 2002-12-17 Kimberly-Clark Worldwide, Inc. Diagnostic test carrier
US6929926B2 (en) 2001-10-15 2005-08-16 Barry J. Marshall Composition for the detection of gastrointestinal disorders
US20030072686A1 (en) * 2001-10-15 2003-04-17 Marshall Barry J. Systems for performing multiple diagnostic tests
US20030073155A1 (en) * 2001-10-15 2003-04-17 Mcmichael Donald J. Methods for performing multiple diagnostic tests
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7008777B2 (en) * 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
USD485359S1 (en) 2001-10-15 2004-01-13 Kimberly-Clark Worldwide, Inc. Specimen-handling tool
USD470241S1 (en) 2001-12-17 2003-02-11 Kimberly-Clark Worldwide, Inc. Specimen-handling tool
USD470597S1 (en) 2001-12-17 2003-02-18 Kimberly-Clark Worldwide, Inc. Diagnostic test kit
USD471639S1 (en) 2001-12-17 2003-03-11 Kimberly-Clark Worldwide, Inc. Tool for handling a specimen
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
USD470596S1 (en) 2001-12-17 2003-02-18 Kimberly-Clark Worldwide, Inc. Test kit specimen-handling tool
USD469881S1 (en) 2001-12-17 2003-02-04 Kimberly-Clark Worldwide, Inc. Two-well diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing
US20040086532A1 (en) * 2002-11-05 2004-05-06 Allergan, Inc., Botulinum toxin formulations for oral administration
WO2007090113A2 (en) 2006-02-01 2007-08-09 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
FR2913403B1 (fr) 2007-03-05 2009-05-29 Astrium Sas Soc Par Actions Si Commande d'actionneur reduisant le niveau de vibrations d'une structure flexible associee
JP2015504881A (ja) * 2011-12-20 2015-02-16 ギリアード サイエンシーズ， インコーポレイテッド 胃腸感染および障害を処置するための医薬組成物および方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301743A (de) * 1962-12-13
FR4961M (de) * 1965-03-29 1967-04-03
FR5877M (de) * 1966-07-22 1968-03-18
FR6197M (de) * 1967-04-12 1968-07-22
US3577533A (en) * 1968-02-21 1971-05-04 Joseph Alfred Rider Antacid compositions containing bismuth aluminate and coprecipitated aluminum hydroxide and magnesium carbonate
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
DE1963496A1 (de) * 1969-12-18 1971-06-24 Hans Voigt Chemisch Pharmazeut Pharmazeutisches Praeparat zur Behandlung von Magen-Darm-Erkrankungen
US4118480A (en) * 1973-02-09 1978-10-03 Charles V. Stoelker Pharmaceutical preparation for treating hemorrhoids and anal fissures
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof

Also Published As

Publication number Publication date
BE904922A (fr) 1986-12-15
PH26891A (en) 1992-11-03
IE861574L (en) 1986-12-13
DE3686362D1 (de) 1992-09-17
EP0206626B2 (de) 2002-05-22
JPS6248624A (ja) 1987-03-03
IE59585B1 (en) 1994-03-09
EP0206626A2 (de) 1986-12-30
ATE79261T1 (de) 1992-08-15
EP0206626B1 (de) 1992-08-12
DE3686362T2 (de) 1993-02-11
EP0206627A3 (en) 1989-04-05
IE861573L (en) 1986-12-13
EP0206627B1 (de) 1992-08-12
JPH0794391B2 (ja) 1995-10-11
IE59584B1 (en) 1994-03-09
DE3686361T2 (de) 1993-02-11
DE3619733A1 (de) 1987-02-12
DE3686361T3 (de) 2003-01-09
US5601848A (en) 1997-02-11
DE3686361D1 (de) 1992-09-17
EP0206627A2 (de) 1986-12-30
EP0206626A3 (en) 1989-04-12
DE3619734A1 (de) 1987-02-12

Similar Documents

Publication Publication Date Title
ATE79264T1 (de) Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.
DE58906894D1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
ATE210979T1 (de) Verwendung rapamycin zur herstellung eines medikaments für die verbeugung und behandlung von hyperproliferativen gefässerkrankheiten, eventuell in kombination mit mycophenolsäure
ATE29729T1 (de) Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus.
ATE446101T1 (de) Verwendung von docosahexaensäure zur herstellung eines arzneimittels zur behandlung der senilen demenz und alzheimer-erkrankung
DE3687501D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE3788184D1 (de) Zahnärztliche Röntgendiagnostikeinrichtung zur Herstellung von Übersichtsaufnahmen von im Schädel verlaufenden Schichten.
DE68910175D1 (de) Adsorbermodul sowie Adsorberapparat zur Behandlung von Vollblut.
DE3875575D1 (de) Verfahren und vorrichtung und vorrichtung zur herstellung und behandlung von transfermembranen.
DE3855527D1 (de) Doppelsträngige RNS zur Korrektur von Abnormalitäten von zirkulierenden Immunkomplexen und der Monozytenfunktion
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
ATE84877T1 (de) Verfahren zur kristallmorphologischen blut- und harnanalyse, zur fruehdiagnose und zur herstellung von arzneimitteln.
ATE216266T1 (de) Einen liganden enthaltendes arzneimittel zur behandlung und/oder diagnose von weichgeweben- tumoren
ZA875201B (en) Device for the transcuticular application of active substances to plants
DE3675115D1 (de) Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star.
DE3787958D1 (de) Abkömmlinge von (trans)- und 13-(cis)-Retionsäure sowie Verfahren zur Herstellung derselben.
LU81578A1 (de) 1,2,3-triazolcarbonsaeureamide,verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
FI901371A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi
DE3674213D1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
LU84495A1 (de) Azolyl-penten-derivate,verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
PT66339A (de) 1,2,3-thiadiazol-5-yl-harnstoffe,verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel zur wachstumsverzoegerung und zur entblaetterung von pflanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0206626

Country of ref document: EP

EELA Cancelled due to lapse of time